MetaADEDB 2.0 @ LMMD
Estramustine
(IIUMCNJTGSMNRO-VVSKJQCTSA-L)
Structure
SMILES
ClCCN(C(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2OP(=O)([O-])[O-])C)CCCl.[Na+].[Na+]
Molecular Formula:
C23H30Cl2NNa2O6P
Molecular Weight:
564.347
Log P:
6.1754
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
0
TPSA:
111.77
CAS Number(s):
52205-73-9
Synonym(s)
1.
Estramustine
2.
Estramustinphosphate
3.
Emcyt
4.
Estracyt
5.
Estramustin Phosphate
6.
Estramustine Phosphate Sodium
7.
Leo-275
8.
NSC-89199
9.
Leo 275
10.
Leo275
11.
NSC 89199
12.
NSC89199
13.
Phosphate Sodium, Estramustine
14.
Phosphate, Estramustin
External Link(s)
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 4US FAERS
2Disease ProgressionFAERS: 3US FAERS
3AnxietyFAERS: 2US FAERS
4ClaustrophobiaFAERS: 2US FAERS
5No adverse eventFAERS: 2US FAERS
6StomatitisFAERS: 2US FAERS
7StressFAERS: 2US FAERS
8ThrombosisFAERS: 2US FAERS
9Abdominal discomfortFAERS: 1US FAERS
10CardiotoxicityFAERS: 1US FAERS
11Cerebral InfarctionFAERS: 1US FAERS
12Circumstance or information capable of leading to medication errorFAERS: 1US FAERS
13DizzinessFAERS: 1US FAERS
14Drug ineffectiveFAERS: 1US FAERS
15DysgeusiaFAERS: 1US FAERS
16Dyspnoea exacerbatedFAERS: 1US FAERS
17DysuriaFAERS: 1US FAERS
18FatigueFAERS: 1US FAERS
19Intentional product misuseFAERS: 1US FAERS
20MalaiseFAERS: 1US FAERS
21Myocardial InfarctionFAERS: 1US FAERS
22Penile swellingFAERS: 1US FAERS
23Peripheral swellingFAERS: 1US FAERS
24Pulmonary EmbolismFAERS: 1US FAERS
25ThrombocytopeniaFAERS: 1US FAERS
26Urinary tract infectionFAERS: 1US FAERS
27Venous ThrombosisFAERS: 1US FAERS
28VomitingFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.